stop semaglutide In the original clinical trials looking at (the GLP-1 in Novo Nordisk's Ozempic and Wegovy) and tirzepatide (in Eli Lilly's Mounjaro and Zepbound), patients gained back most of the weight after Stopping Semaglutide: Effects, Weight Gain

Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver

In the subpopulation of participants from the China region (75.2% of trial participants), reductions in HbA 1c and body weight from baseline to week 26 were similar to those seen in the overall population

A 2022 meta-analysis published in Obesity Reviews found that participants taking GLP-1 receptor agonists typically experienced 25 to 40% of their weight loss from lean masswithin an expected and manageable range when considering dietary interventions or bariatric surgery

Conclusion GLp-1 medications can cause diarrhea because they affect digestion and stomach emptying